Does THYMOCYTE IMMUNE GLOBULIN NOS Cause Off label use? 749 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 749 reports of Off label use have been filed in association with THYMOCYTE IMMUNE GLOBULIN NOS. This represents 13.5% of all adverse event reports for THYMOCYTE IMMUNE GLOBULIN NOS.
749
Reports of Off label use with THYMOCYTE IMMUNE GLOBULIN NOS
13.5%
of all THYMOCYTE IMMUNE GLOBULIN NOS reports
242
Deaths
300
Hospitalizations
How Dangerous Is Off label use From THYMOCYTE IMMUNE GLOBULIN NOS?
Of the 749 reports, 242 (32.3%) resulted in death, 300 (40.1%) required hospitalization, and 99 (13.2%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for THYMOCYTE IMMUNE GLOBULIN NOS. However, 749 reports have been filed with the FAERS database.
What Other Side Effects Does THYMOCYTE IMMUNE GLOBULIN NOS Cause?
Drug ineffective (692)
Cytomegalovirus infection (404)
Product use in unapproved indication (396)
Transplant rejection (340)
Post transplant lymphoproliferative disorder (319)
Epstein-barr virus infection (255)
Pneumonia (254)
Multiple organ dysfunction syndrome (250)
Coma (247)
Pneumonia aspiration (239)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which THYMOCYTE IMMUNE GLOBULIN NOS Alternatives Have Lower Off label use Risk?
THYMOCYTE IMMUNE GLOBULIN NOS vs THYMOGLOBULINE
THYMOCYTE IMMUNE GLOBULIN NOS vs THYMOL
THYMOCYTE IMMUNE GLOBULIN NOS vs THYROID, PORCINE
THYMOCYTE IMMUNE GLOBULIN NOS vs THYROID, PORCINE\THYROID, UNSPECIFIED
THYMOCYTE IMMUNE GLOBULIN NOS vs THYROTROPIN ALFA